| By Tipranks

EUDA Health Holdings has announced the upcoming launch of EUDA Helixé 2.0, the next-generation version of its premium longevity and youthful vitality supplement, scheduled for January 2026. The product marks a significant upgrade in formulation, delivery technology, and market positioning as the company continues to scale its presence in preventive healthcare and wellness.

Reformulated Ingredients for Enhanced Cellular Support

Helixé 2.0 features a 20 percent increase in New Zealand deer placenta powder, reinforcing its positioning as a high-end longevity supplement. The formulation has also been enhanced with a refined antioxidant profile, including Vitamin E, aimed at supporting cellular protection and skin health.

According to the company, the updated ingredient composition is designed to meet growing consumer demand for science-backed wellness products that address aging-related health concerns.

Advanced Processing Technology Improves Absorption and Stability

Beyond formulation, EUDA Health has introduced multiple advanced processing technologies to improve product performance. These include freeze drying, refined oil processing, nitrogen encapsulation, and nano-emulsification, all intended to enhance nutrient absorption, product stability, and shelf life.

The company is also rolling out a new proprietary bottle design, reinforcing brand identity while providing improved protection for the supplement.

Halal Certification Opens Access to Muslim Consumer Markets

A key element of the Helixé 2.0 launch is the product’s New Zealand Halal certification, positioning it for entry into Muslim-majority and halal-conscious markets across Southeast Asia, the Middle East, and other regions.

By securing halal certification, EUDA Health aims to align premium longevity products with Islamic dietary compliance, expanding accessibility to Muslim consumers seeking halal-certified wellness solutions.

A Core Pillar of EUDA’s Preventive Healthcare Strategy

EUDA Health has positioned Helixé 2.0 as a central component of its broader health and longevity ecosystem. The launch supports the company’s long-term strategy to scale premium, evidence-based wellness offerings while capitalizing on high-growth segments within preventive care and longevity-focused healthcare.

Analysts currently maintain a Buy rating on EUDA Health Holdings stock, reflecting confidence in the company’s expansion strategy and product pipeline.

About EUDA Health Holdings

EUDA Health Holdings Limited is a Singapore-based, non-invasive healthcare provider operating across Singapore, Malaysia, and China. Listed on Nasdaq, the company focuses on preventive care and longevity solutions, targeting the healthcare needs of rapidly aging populations across Asia. In addition to healthcare services, EUDA Health also operates a Singapore-based property management business.

Source:

TipRanks. (2025). Euda Health to launch Helixe 2.0 longevity supplement with halal certification in January 2026. https://www.tipranks.com/news/company-announcements/euda-health-to-launch-helixe-2-0-longevity-supplement-with-halal-certification-in-january-2026